State Street Corp Portage Biotech Inc. Transaction History

State Street Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.16 - $11.95 $359,492 - $832,544	-69,669 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.57 - $12.0 $1,589 - $2,904	242 Added 0.35%	69,669 $458,000
Q4 2021 Feb 14, 2022	SELL	$10.73 - $23.74 $3,680 - $8,142	-343 Reduced 0.49%	69,427 $745,000
Q3 2021 Nov 15, 2021	BUY	$13.65 - $22.4 $318,277 - $522,300	23,317 Added 50.19%	69,770 $1.42 Million
Q2 2021 Aug 16, 2021	BUY	$20.96 - $42.81 $973,654 - $1.99 Million	46,453 New	46,453 $974,000

2.16M

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $3.56M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.